Final Program

MONDAY • MAY 16 171
P947
P948
P949
P950
P951
Facilitator:
P952
P953
P954
P955
P956
P957
P958
The Relationship Among Pulmonary Function, Exacerbation
and ICU Admission Rate and Pulmonary Artery Enlargement in
Patients with Advanced Chronic Obstructive Pulmonary
Disease/A. Sadigov, I. Isayev, A. Bagirzadeh, Baku, Azerbaijan,
p.A3531
Longitudinal Changes in FEV1, Hyperinflation, and 6-Minute
Walk Distance in Patients with COPD Associated with
Non-Cystic Fibrosis Bronchiectasis/A. Sadigov, K.
Bakhshaliyeva, S. Guliyeva, Baku, Azerbaijan, p.A3532
Decreased Exacerbation Risk in COPD Correlates with
Therapeutic Improvement in FEV1: A Meta-Analysis of
Randomized, Controlled Trials/A.D. Zider, R.G. Buhr, X. Wang, W.
Sirichana, I. Barjaktarevic, C.B. Cooper, Los Angeles, CA, p.A3533
Clinically Significant Impact of Tiotropium and Indacaterol on
Six-Minute Walking Test and Inspiratory Capacity in Women
with Chronic Obstructive Pulmonary Disease Associated to
Biomass Exposure/M. Velazquez-Uncal, A. Ramirez-Venegas,
R.H. Sansores, O. Perez-Bautista, R. Hernandez-Zenteno, A.
Velazquez, F. Flores, C. Sanchez, C. Espinosa De Los Monteros,
A. Aranda-Chavez, Mexico, Mexico, p.A3534
Response of Respiratory Symptoms in Outpatient Chronic
Obstructive Pulmonary Disease Patients to Administration of
Prednisone Therapy/P. Mulhall, A.J. Criner, M.R. Jacobs, G.J.
Criner, Phildelphia, PA, p.A3535
A.P. Comellas, MD, Iowa City, IA
The Relationship Between the Number of Natural Teeth and
Airflow Obstruction: A Cross-Sectional Study Using Data from
KNHANES/S.W. Kim, C.K. Rhee, Y.H. Kim, H.K. Yoon, Seoul,
Korea, Republic of, p.A3536
Health Related Quality of Life in Indian Patients of Chronic
Obstructive Pulmonary Disease/D.P. Bhadoria, V.P. Ghilley, L.
Kumar, T. Raghuvanshi, P. Bhadoria, New Delhi, India, p.A3537
Clinical and Functional Characteristics of Elderly Chronic
Obstructive Pulmonary Disease Patients/S. Nayci, E.S. Ozgur,
C. Ozge, E. Tas?tekin, A. llvan, Mersin, Turkey, p.A3538
Prognostic Factors of Patients Who Hospitalized for COPD
Exacerbation; a Single Institutional Study/M. Sato, S. Inoue, A.
Igarashi, Y. Tokairin, T. Nemoto, K. Sato, M. Kobayashi, Y. Abe, I.
Kubota, Y. Shibata, Yamagata, Japan, p.A3539
The Development and Application of a Number-Axis System
for Diagnosis, Treatment and Prediction of Outcome on
Bronchial Asthma, Chronic Obstructive Pulmonary Disease
(COPD) and Overlap Syndrome/J.-Z. Cao, H.-W. Lin, Tianjin,
China, p.A3540
Incident Opioid Drug Use and Adverse Respiratory Outcomes
Among Older Adults with COPD/N.T. Vozoris, X. Wang, H.
Fischer, C. Bell, D.E. O’Donnell, P. Austin, A.L. Stephenson, S.S.
Gill, P.A. Rochon, Toronto, Canada, p.A3541
Characteristics of Daily Physical Activity in Patients with
Chronic Obstructive Pulmonary Disease and Association with
Acute Exacerbations/N. Yee, H.Q. Nguyen, K.C. Pike, Z. Chen, J.
Lee, V.S. Fan, Seattle, WA, p.A3542
P959
P960
Facilitator:
P961
P962
P963
P964
P965
P966
P967
P968
P969
P970
Mild COPD Patients with a High Symptom Load: A Subgroup
Analysis from the DACCORD Registry/P. Kardos, R. Buhl, C.-P.
Criee, C. Vogelmeier, N. Lossi, C. Mailaender, H. Worth, Frankfurt,
Germany, p.A3543
Ten Years’ Mortality Data of Patients with Chronic Obstructive
Pulmonary Disease from the Hokkaido COPD Cohort Study/H.
Makita, M. Suzuki, S. Konno, K. Shimizu, Y.M. Ito, M. Nishimura,
Sapporo, Japan, p.A3544
A.A. Diaz, MD, Boston, MA
Adverse Events Among COPD Patients Treated with
Long-Acting Anticholinergics and b2-Agonists in an
Outpatient Respiratory Clinic/C. Rodrigue, M.-F. Beauchesne, F.
Savaria, A. Forget, C. Lemiere, P. Larivee, L. Blais, Montreal,
Canada, p.A3545
Chronic Obstructive Pulmonary Disease (COPD) and
Pneumonia (PN) Related Risk Variables and Ultimate Mortality
Outcome/J.B. Glaser, D. Pau, N.K. Mobarakai, M. Castellano,
Staten Island, NY, p.A3546
BODEx Index and Multidimensional Evaluation of COPD
Patients at the Altitude of Bogota (2640 m)/C.A. Celis Preciado,
A. Canas-Arboleda, J. Lasso, C. Villaquiran-Torres, J.R. Lutz,
Bogota, Colombia, p.A3547
Sedation and Physiological Response to Intranasal
Dexmedetomidine (IN-DEX) in Patients with Severe Chronic
Obstructive Pulmonary Disease (COPD)/J.C. Rojas-Gomez, P.
Nystrom, Dayton, OH, p.A3548
Facial Wrinkling Is Associated with Emphysema Independent
of Airflow Obstruction: The Pittsburgh SCCOR Cohort/R.C.
Wilson, D. Chandra, J.M. Bon, C.M. Karoleski, C. Fuhrman, J.K.
Leader, Y. Zhang, A.M. Morris, Z. Urban, F.C. Sciurba, Pittsburgh,
PA, p.A3549
The Relationship Between Serum Ferritin Concentration and
Lung Function in Korean People/S. Myung Jin, E.K. Goag, S.Y.
Kim, Y.S. Kim, Seodaemun-gu, Seoul, Korea, Republic of, p.A3550
Clinical Characteristics of COPD Patients with Robust
Emphysema Progression/A. Tsutsumi, S. Chubachi, M. Sasaki,
M. Sato, N. Kameyama, T. Shirahata, H. Koh, Y. Oyamada, T.
Inoue, H. Nakamura, K. Asano, T. Betsuyaku, Tokyo, Japan,
p.A3551
Association of Respiratory Muscle Weakness with Cardiac
Autonomic Modulation in Patients with Chronic Obstructive
Pulmonary Disease/R. Trimer, C.L. Goulart, J.C. Simon, N.A. Da
Fonseca Miranda, P.D.B. Schneiders, E.A. San Martin, A.
Borghi-Silva, A.L.G. Da Silva, Sao Carlos, Brazil, p.A3552
Results of a Pulmonologist Survey Regarding Attitudes and
Practices with Inhalation Devices for COPD/S.S. Braman, B.W.
Carlin, R. Dhand, N.A. Hanania, D.A. Mahler, J.A. Ohar, V. Pinto-Plata,
T. Shah, M. Turenne, D. Eubanks, New York, NY, p.A7816
Efficiency of Neural Respiratory Drive for the Assessment of
Bronchodilator Responsiveness in Patients with Chronic
Obstructive Pulmonary Disease: An Exploratory Study/X.
Chen, Y. Li, Y.-H. Li, Y.-W. Luo, K. Wang, Y.-T. Chen, Guangzhou,
China, p.A7817
MONDAY MORNING
ATS 2016 • San Francisco